Place of surgery before and after concurrent chemoradiotherapy for locally advanced cervical carcinoma: A retrospective study of 102 cases;Place de la chirurgie avant et après radiochimiothérapie des cancers du col localement évolués : à propos de 102 cas

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 40, Issue 1, 2011, Pages 11-21

  Lavoue V ^a,b   Voguet, L ^c   Bertel, C ^a   Mesbah, H ^b   Williaume, D ^b   Laguerre, B ^b   Poree P ^b   Foucher, F ^a,b   Montpetit, E ^d   Leblanc, M ^c   Leveque J ^a,b  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b CRLCC Eugne Marquis   (France)

^c Centre Hospitalier Bretagne Atlantique   (France)

^d Clinique St Yves   (France)

Author keywords

Chemotherapy; Hysterectomy; Lymphadenectomy; Radiotherapy; Uterine cervical carcinoma

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; RETROSPECTIVE STUDY; UTERINE CERVIX CARCINOMA;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79151470569     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgyn.2010.10.008     Document Type: Article

References (35)

1. H.M. Keys, B.N. Bundy, F.B. Stehman, L.I. Muderspach, W.E. Chafe, and C.L. Suggs 3rd. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161
2. M. Morris, P.J. Eifel, J. Lu, P.W. Grigsby, C. Levenback, and R.E. Stevens Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
3. C.W. Whitney, W. Sause, B.N. Bundy, J.H. Malfetano, E.V. Hannigan, and W.C. Fowler Jr. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a gynecologic oncology group and southwest oncology group study J Clin Oncol 17 1999 1339 1348
4. P.G. Rose, B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, and M.A. Maiman Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
5. W.A. Peters 3rd., P.Y. Liu, R.J. Barrett 2nd., R.J. Stock, B.J. Monk, and J.S. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
6. J.A. Green, J.M. Kirwan, J.F. Tierney, P. Symonds, L. Fresco, and M. Collingwood Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis Lancet 358 2001 781 786
7. J. Green, J. Kirwan, J. Tierney, C. Vale, P. Symonds, and L. Fresco Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix Cochrane Database Syst Rev 3 2005 CD002225
8. B.J. Monk, C. Tian, P.G. Rose, and R. Lanciano Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two gynecologic oncology group (GOG) trials Gynecol Oncol 105 2007 427 433
9. FNLCC. Standards, options et recommandations. Cancers invasifs du col utérin. Stades non métastatiques. FNLCC; 1999.
10. R. Rouzier, P. Morice, R. De Crevoisier, C. Pomel, A. Rey, and K. Bonnet Survival in cervix cancer patients treated with radiotherapy followed by radical surgery Eur J Surg Oncol 31 2005 424 433
11. W.C. Lin, Y.C. Hung, L.S. Yeh, C.H. Kao, R.F. Yen, and Y.Y. Shen Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings Gynecol Oncol 89 2003 73 76
12. L.S. Yeh, Y.C. Hung, Y.Y. Shen, C.H. Kao, C.C. Lin, and C.C. Lee Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings Oncol Rep 9 2002 1289 1292
13. P.G. Rose, L.P. Adler, M. Rodriguez, P.F. Faulhaber, F.W. Abdul-Karim, and F. Miraldi Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study J Clin Oncol 17 1999 41 45
14. H.J. Choi, J.W. Roh, S.S. Seo, S. Lee, J.Y. Kim, and S.K. Kim Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study Cancer 106 2006 914 922
15. E. Leblanc, F. Narducci, M. Frumovitz, A. Lesoin, B. Castelain, and M.C. Baranzelli Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma Gynecol Oncol 105 2007 304 311
16. V. Lavoue, A.S. Bats, R. Rouzier, C. Coutant, E. Barranger, and E. Darai Sentinel lymph node procedure followed by laparoscopic pelvic and paraaortic lymphadenectomy in women with IB2-II cervical cancer Ann Surg Oncol 14 2007 2654 2661
17. V. Lavoue, A.S. Bats, and E. Darai Pelvic and para-aortic lymphadenectomy are required to stage locally advanced cervical cancer Gynecol Oncol 109 2008 427 428 [author reply 428-9]
18. G. Houvenaeghel, L. Lelievre, A.L. Rigouard, M. Buttarelli, J. Jacquemier, and P. Viens Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer Gynecol Oncol 102 2006 74 79
19. J.M. Classe, P. Rauch, J.F. Rodier, P. Morice, E. Stoeckle, and S. Lasry Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (groupe des chirurgiens de centre de lutte contre le cancer) Gynecol Oncol 102 2006 523 529
20. H.M. Keys, B.N. Bundy, F.B. Stehman, T. Okagaki, D.G. Gallup, and A.F. Burnett Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the gynecologic oncology group Gynecol Oncol 89 2003 343 353
21. S. Pecorelli, J.L. Benedet, W.T. Creasman, J.H. Shepherd International Federation of Gynecology and Obstetrics FIGO staging of gynecologic cancer. 1994-1997 FIGO committee on gynecologic oncology Int J Gynaecol Obstet 64 1999 5 10
22. D. Chassagne, P. Sismondi, J.C. Horiot, G. Sinistrero, P. Bey, and P. Zola A glossary for reporting complications of treatment in gynecological cancers Radiother Oncol 26 1993 195 202
23. C.H. Lai, H.C. Chang, T.C. Chang, S. Hsueh, and S.G. Tang Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases Gynecol Oncol 51 1993 390 396
24. P. Morice, D. Castaigne, P. Pautier, A. Rey, C. Haie-Meder, and M. Leblanc Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma Gynecol Oncol 73 1999 106 110
25. M.L. Berman, H. Keys, W. Creasman, P. DiSaia, B. Bundy, and J. Blessing Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a gynecologic oncology group study) Gynecol Oncol 19 1984 8 16
26. L.J. Havrilesky, C.A. Leath, W. Huh, B. Calingaert, R.C. Bentley, and J.T. Soper Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer Gynecol Oncol 93 2004 429 434
27. N. Sakuragi, C. Satoh, N. Takeda, H. Hareyama, M. Takeda, and R. Yamamoto Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy Cancer 85 1999 1547 1554
28. E. Barranger, C. Coutant, A. Cortez, S. Uzan, and E. Darai Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease Ann Oncol 16 2005 1237 1242
29. V. Lavoue, C. Nos, K.B. Clough, F. Baghaie, E. Zerbib, and B. Poulet Simplified technique of radioguided occult lesion localization (ROLL) plus sentinel lymph node biopsy (SNOLL) in breast carcinoma Ann Surg Oncol 15 2008 2556 2561
30. L.J. Havrilesky, S.L. Kulasingam, D.B. Matchar, and E.R. Myers FDG-PET for management of cervical and ovarian cancer Gynecol Oncol 97 2005 183 191
31. C.H. Lai, K.G. Huang, J.H. Hong, C.L. Lee, H.H. Chou, and T.C. Chang Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer Gynecol Oncol 89 2003 160 167
32. Y. Delpech, L. Tulpin, A. Bricou, E. Barranger, Y. Delpech, and L. Tulpin Stadification ganglionnaire des cancers du col utérin avancés Gynecol Obstet Fertil 38 2010 30 35
33. P. Morice, C. Uzan, Y. Zafrani, Y. Delpech, S. Gouy, and C. Haie-Meder The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer Gynecol Oncol 107 2007 S122 S124
34. D.H. Moore Surgical staging and cervical cancer: after 30 years, have we reached a conclusion? Cancer 112 2008 1874 1876
35. E. Azria, P. Morice, C. Haie-Meder, A. Thoury, P. Pautier, and C. Lhomme Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma Ann Surg Oncol 12 2005 332 337